Not Rated
Fund Size
(0.07% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 01-Sep-25 | 10104.50 | 1.04% | - | 0.80% | 73/237 |
1 Month | 08-Aug-25 | 10312.50 | 3.12% | - | 2.70% | 88/236 |
3 Month | 06-Jun-25 | 10247.60 | 2.48% | - | 1.08% | 78/228 |
6 Month | 07-Mar-25 | 11077.20 | 10.77% | - | 13.20% | 153/224 |
YTD | 01-Jan-25 | 9674.20 | -3.26% | - | 1.39% | 163/214 |
Since Inception | 27-Dec-24 | 9769.00 | -2.31% | -3.29% | 11.91% | 204/218 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
No Data Found |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Divis Laboratories Ltd. | Pharmaceuticals | 270.9 | 7.94% | -0.73% | 9.27% (Apr 2025) | 0% (Aug 2024) | 41.08 k | -1.22 k |
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 255.4 | 7.48% | -0.07% | 8.83% (Apr 2025) | 0% (Aug 2024) | 1.50 L | 0.00 |
Apollo Hospitals Enterprises Ltd. | Hospital | 205.1 | 6.01% | 0.05% | 6.01% (Jul 2025) | 0% (Aug 2024) | 27.36 k | 0.00 |
Cipla Ltd. | Pharmaceuticals | 181.6 | 5.32% | -0.76% | 8.33% (Apr 2025) | 0% (Aug 2024) | 1.17 L | -0.17 L |
Biocon Ltd. | Pharmaceuticals | 128.2 | 3.76% | 0.25% | 4.24% (Jan 2025) | 0% (Aug 2024) | 3.28 L | 0.00 |
Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 117.6 | 3.45% | -0.06% | 3.51% (Jun 2025) | 0% (Aug 2024) | 55.11 k | -0.11 L |
Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 115.6 | 3.39% | 0.20% | 3.4% (May 2025) | 0% (Aug 2024) | 82.00 k | 0.00 |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 114.9 | 3.37% | -0.12% | 8.46% (Jan 2025) | 0% (Aug 2024) | 90.44 k | 0.00 |
Syngene International Ltd. | Healthcare research, analytics & technology | 110.8 | 3.25% | 0.72% | 3.25% (Jul 2025) | 0% (Aug 2024) | 1.55 L | 23.66 k |
Fortis Healthcare Ltd. | Hospital | 109.3 | 3.20% | 0.76% | 3.2% (Jul 2025) | 0% (Aug 2024) | 1.27 L | 25.54 k |
Name | Type of Instrument | Weight (%) |
---|---|---|
Net Receivables | Net Receivables | 3.08% |
TREPS | TREPS | 0.17% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 351.43 | 11.22 | 37.07 | 45.24 | 50.80 | 31.16 |
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 229.26 | 2.12 | 9.38 | 14.61 | 26.45 | 16.56 |
Nippon India US Equity Opportunities Fund - Growth | NA | 705.95 | 2.90 | 5.20 | 6.26 | 19.19 | 17.93 |
Motilal Oswal Business Cycle Fund - Regular Plan - Growth | NA | 1949.73 | 7.14 | 4.73 | 14.07 | 18.90 | 0.00 |
Nippon India Japan Equity Fund - Growth | NA | 273.12 | 2.88 | 9.73 | 13.87 | 16.98 | 17.32 |
Franklin Asian Equity Fund - Growth | NA | 270.18 | 2.42 | 7.48 | 11.85 | 15.50 | 10.36 |
DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1346.44 | 0.74 | -2.55 | 12.70 | 13.00 | 0.00 |
HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1450.98 | 12.72 | 18.54 | 34.51 | 12.08 | 0.00 |
SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8450.07 | -0.15 | -0.48 | 15.89 | 10.84 | 17.10 |
Motilal Oswal Manufacturing Fund - Regular Plan - Growth | NA | 774.69 | 5.86 | 2.58 | 19.52 | 10.60 | 0.00 |
Out of 22 mutual fund schemes offered by this AMC, 1 is/are ranked 4 * , 1 is/are ranked 3 * , 1 is/are ranked 2 * , and 19 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Bajaj Finserv Money Market Fund - Regular Plan - Growth | 3 | 5828.18 | 0.37 | 1.45 | 3.88 | 7.41 | 0.00 |
Bajaj Finserv Flexi Cap Fund - Regular Plan - Growth | NA | 5244.12 | 0.25 | 1.45 | 17.12 | 1.22 | 0.00 |
Bajaj Finserv Liquid Fund - Regular Plan - Growth | 4 | 4554.89 | 0.46 | 1.43 | 3.24 | 6.82 | 0.00 |
Bajaj Finserv Large and Mid Cap Fund - Regular Plan - Growth | NA | 2098.13 | -0.29 | -0.48 | 12.16 | -2.83 | 0.00 |
Bajaj Finserv Large Cap Fund - Regular Plan - Growth | NA | 1501.12 | 0.85 | 0.00 | 11.55 | -2.52 | 0.00 |
Bajaj Finserv Balanced Advantage - Regular Plan - Growth | NA | 1298.54 | 0.21 | -0.29 | 8.99 | -1.68 | 0.00 |
Bajaj Finserv Small Cap Fund - Regular Plan - Growth | NA | 1201.14 | -1.43 | 0.00 | 0.00 | 0.00 | 0.00 |
Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1190.92 | 0.89 | 1.16 | 9.69 | 0.62 | 0.00 |
Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1190.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bajaj Finserv Nifty 1D Rate Liquid ETF - Growth | NA | 965.32 | 0.43 | 1.26 | 2.70 | 4.65 | 0.00 |